Search Results - "Hurst, HC"

Refine Results
  1. 1

    Expression of the ERBB3 gene product in breast cancer by LEMOINE, N. R, BARNES, D. M, HOLLYWOOD, D. P, HUGHES, C. M, SMITH, P, DUBLIN, E, PRIGENT, S. A, GULLICK, W. J, HURST, H. C

    Published in British journal of cancer (01-12-1992)
    “…Abnormalities of the EGF receptor and/or the related ERBB2 receptor occur in a significant proportion of cases of human breast cancer and are important…”
    Get full text
    Journal Article
  2. 2

    Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes by Belandia, Borja, Orford, Rob L., Hurst, Helen C., Parker, Malcolm G.

    Published in The EMBO journal (01-08-2002)
    “…SWI/SNF complexes are ATP‐dependent chromatin remodelling enzymes that have been implicated in the regulation of gene expression in yeast and higher…”
    Get full text
    Journal Article
  3. 3

    Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator by Bamforth, Simon D, Marques, Fatima I.R, Kranc, Kamil R, Hurst, Helen C, Farza, Hend, Bragança, José, Eloranta, Jyrki J, Bhattacharya, Shoumo, Murdoch, Jennifer N, Henderson, Deborah J

    Published in Nature genetics (01-12-2001)
    “…The protein EP300 and its paralog CREBBP (CREB-binding protein) are ubiquitously expressed transcriptional co-activators and histone acetyl transferases. The…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Physical and Functional Interactions among AP-2 Transcription Factors, p300/CREB-binding Protein, and CITED2 by Bragança, José, Eloranta, Jyrki J., Bamforth, Simon D., Ibbitt, J. Claire, Hurst, Helen C., Bhattacharya, Shoumo

    Published in The Journal of biological chemistry (02-05-2003)
    “…The transcriptional co-activators and histone acetyltransferases p300/CREB-binding protein (CBP) interact with CITED2, a transcription factor AP-2 (TFAP2)…”
    Get full text
    Journal Article
  7. 7

    Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival by Gee, JMW, Eloranta, JJ, Ibbitt, JC, Robertson, JFR, Ellis, IO, Williams, T, Nicholson, RI, Hurst, HC

    Published in The Journal of pathology (2009)
    “…The AP-2γ transcription factor encoded by the TFAP2C gene is a member of a family of homologous DNA binding proteins that play essential roles during…”
    Get full text
    Journal Article
  8. 8

    Transcription Factor AP-2 Interacts with the SUMO-conjugating Enzyme UBC9 and Is Sumolated in Vivo by Eloranta, Jyrki J, Hurst, Helen C

    Published in The Journal of biological chemistry (23-08-2002)
    “…The members of the AP-2 family of transcription factors are developmentally regulated and have distinct yet overlapping functions in the regulation of many…”
    Get full text
    Journal Article
  9. 9

    Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types by Srinivasan, Radhika, Poulsom, Richard, Hurst, Helen C., Gullick, William J.

    Published in The Journal of pathology (01-07-1998)
    “…The c‐erbB‐4/HER4 receptor belongs to the family of the type I growth factor receptors. Mouse monoclonal antibodies have been raised to the cytoplasmic domain…”
    Get full text
    Journal Article
  10. 10

    Competition on nitrocellulose-immobilized antibody arrays: from bacterial protein binding assay to protein profiling in breast cancer cells by Yeretssian, Garabet, Lecocq, Michèle, Lebon, Guillaume, Hurst, Helen C, Sakanyan, Vehary

    Published in Molecular & cellular proteomics (01-05-2005)
    “…Large scale comparative evaluation of protein expression requires miniaturized techniques to provide sensitive and accurate measurements of the abundance of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma by Bosher, J M, Totty, N F, Hsuan, J J, Williams, T, Hurst, H C

    Published in Oncogene (17-10-1996)
    “…The proto-oncogene c-erbB-2 is overexpressed in 25-30% of breast cancers through increased transcription and amplification of the gene. We have previously…”
    Get more information
    Journal Article
  13. 13

    RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2 by Batsché, Eric, Muchardt, Christian, Behrens, Jürgen, Hurst, Helen C., Crémisi, Chantal

    Published in Molecular and Cellular Biology (01-07-1998)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment by Hurst, H C

    Published in Breast cancer research : BCR (2001)
    “…Overexpression of the ERBB2 proto-oncogene is associated with amplification of the gene in breast cancer but increased activity of the promoter also plays a…”
    Get full text
    Journal Article
  15. 15

    The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma by Bosher, J M, Williams, T, Hurst, H C

    “…Overexpression of the c-erbB-2/HER2 protooncogene in breast carcinoma is controlled not only by the degree of amplification of the gene but also at the level…”
    Get full text
    Journal Article
  16. 16

    Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways by TURNER, B. C, JIAN ZHANG, GUMBS, A. A, MAHER, M. G, KAPLAN, L, CARTER, D, GLAZER, P. M, HURST, H. C, HAFFTY, B. G, WILLIAMS, T

    Published in Cancer research (Chicago, Ill.) (01-12-1998)
    “…The AP-2 transcription factors are required for normal growth and morphogenesis during mammalian development. Previous in vitro studies have also indicated…”
    Get full text
    Journal Article
  17. 17

    Genetic Prodrug Activation Therapy for Breast Cancer: A Phase I Clinical Trial of erbB-2–Directed Suicide Gene Expression by PANDHA, H. S, MARTIN, L.-A, RIGG, A, HURST, H. C, STAMP, G. W. H, SIKORA, K, LEMOINE, N. R

    Published in Journal of clinical oncology (01-07-1999)
    “…This trial was designed to test the safety and efficacy of a tumor-specific genetic prodrug activation therapy targeted by use of the human erbB-2 gene…”
    Get full text
    Journal Article
  18. 18

    FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1α by SHAH, Riyaz N. H, IBBITT, J. Claire, ALITALO, Kari, HURST, Helen C

    Published in Oncogene (28-11-2002)
    “…Fibroblast growth factor receptor 4 (FGFR4) is expressed in 50–70% of pancreatic carcinomas (PC) and a similar proportion of derived cell lines. Here we…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer by NEWMAN, S. P, BATES, N. P, VERNIMMEN, D, PARKER, M. G, HURST, H. C

    Published in Oncogene (27-01-2000)
    “…Overexpression of the ERBB2 proto-oncogene in breast tumours, which occurs in 25-30% of patients, correlates with poor prognosis. In oestrogen receptor (ER)…”
    Get full text
    Journal Article